Syncom Formulations (India) consolidated net profit rises 45.46% in the December 2025 quarter
Sales decline 9.72% to Rs 115.14 crore
Net profit of Syncom Formulations (India) rose 45.46% to Rs 18.91 crore in the quarter ended December 2025 as against Rs 13.00 crore during the previous quarter ended December 2024. Sales declined 9.72% to Rs 115.14 crore in the quarter ended December 2025 as against Rs 127.53 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales115.14127.53 -10 OPM %18.4211.55 -PBDT26.4518.57 42 PBT25.0917.26 45 NP18.9113.00 45Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 12 2026 | 6:37 PM IST